Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H18ClNO4 |
| Molecular Weight | 335.782 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCC2=NC(CO)=CC=C2
InChI
InChIKey=YJBIJSVYPHRVCI-UHFFFAOYSA-N
InChI=1S/C17H18ClNO4/c1-17(2,23-15-8-6-12(18)7-9-15)16(21)22-11-14-5-3-4-13(10-20)19-14/h3-9,20H,10-11H2,1-2H3
| Molecular Formula | C17H18ClNO4 |
| Molecular Weight | 335.782 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Pirifibrate is a fibric acid derivative. Pirifibrate was used in the treatment of hyperlipoproteinemia (HLP). After treatment with pirifibrate, mean plasma levels of cholesterol fell about 20% in types IIa and IIb HLP; triglycerides fell between 30% and 46% in types IIb and IV HLP. Slight increases in alpha-lipoproteins in the three types of HLP were measured. Prebeta-lipoprotein levels fell considerably in types IIb and IV. The variations observed in beta-lipoprotein levels were significant only in type IV, which initially showed low values.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study. | 1980 |
|
| Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV. | 1980 |
|
| [Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)]. | 1980 Dec |
|
| Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations. | 1981 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:27:23 GMT 2023
by
admin
on
Sat Dec 16 16:27:23 GMT 2023
|
| Record UNII |
E82B3Z65BN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C98150
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081648
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
C028670
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
4521
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
SUB09913MIG
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
68720
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
DTXSID30203789
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
m8878
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
2204
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
CHEMBL153867
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
C66421
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
55285-45-5
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY | |||
|
E82B3Z65BN
Created by
admin on Sat Dec 16 16:27:23 GMT 2023 , Edited by admin on Sat Dec 16 16:27:23 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
